Vol 57, No 4 (2006)
Original paper
Published online: 2006-07-07

open access

Page views 556
Article views/downloads 1246
Get Citation

Connect on Social Media

Connect on Social Media

Application of 13-cis-retinoic acid in patients with 131I scintigraphically-negative metastases of differentiated thyroid carcinoma

Zbigniew Adamczewski, Jacek Makarewicz, Sławomir Mikosiński, Małgorzata Knapska-Kucharska, Anna Gunerska-Szadkowska, Lidia Oszukowska, Anzelmina Karwowska, Andrzej Lewiński
Endokrynol Pol 2006;57(4):403-406.

Abstract

Introduction: The loss of iodine uptake by differentiated thyroid carcinoma (DTC) cells is a major therapeutic problem especially in patients with nonsurgical metastatic foci or local recurrence. Using 13-cis-retinoic acid, it was attempted to retain iodine uptake as a result of redifferentiation (influence by retinoic acid receptors present in DTC cells).
Material and methods: Between 1999 and 2005, 13-cis-retinoic acid was used in 11 patients with disseminated PTC and high serum level of thyroglobulin (Tg) before 131I treatment (2 patients were treated twice - 13 treatment cycles in total). Side effects in skin and mucous membranes were observed in all the patients, however, their intensity did not require termination of the therapy.
Results: Increase of iodine uptake was observed in 5 patients (45%). Decreased Tg concentration was observed in 9 patients. In that group, increased 131I uptake was observed in 4 patients with distant metastases. All determinations of Tg concentrations were carried out under TSH stimulation.
Conclusions: 13-cis-retinoic acid causes an increase of radioiodine uptake in around half of treated patients, however, the follow-up of these patients indicates that this increase does not result in either full remission or even stabilisation of neoplastic disease. The possibility should be considered to use cis-retinoic acid as an independent therapeutic approach in patients with radioiodine non-avid foci of thyroid carcinoma especially those showing high expression of RARb and RXRg receptors.

Article available in PDF format

View PDF (Polish) Download PDF file